Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810816) titled 'Prospective Pharmacogenetic Cohort Study of CYP2D6 Metabolizer Phenotype, Analgesic Failure, and Adverse Effects in Postoperative Patients Receiving Tramadol by Elastomeric Infusion Pump' on Sept. 3.
Study Type: Observational [Patient Registry]
Primary Sponsor: Research Inc
Condition:
Acute Postoperative Pain
Tramadol Adverse Effect
Pharmacogenetic Variation
Intervention:
Drug: Standardized Tramadol Elastomeric Analgesia Pump
Recruitment Status: Recruiting
Date of First Enrollment: January 12, 2023
Target Sample Size: 200
Countries of Recruitment:
Colombia
To know more, visit https://clinicaltrials.gov/s...